Essien, Utibe R.

Racial and Ethnic Disparities in Population-Level Covid-19 Mortality

Gross, C. P., Essien, U. R., Pasha, S., Gross, J. R., Wang, S.-Y., & Nunez-Smith, M. (2020) · Journal of General Internal Medicine

COVID-19 epidemiological studiesCOVID-19 Clinical Research Studies

Cited by 410

Association of race/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US

Eberly, L. A., Yang, L., Eneanya, N. D., Essien, U., Julien, H., Nathan, A. S., Khatana, S. A. M., Dayoub, E. J., Fanaroff, A. C., Giri, J., et al. (2021) · JAMA Network Open

Diabetes Treatment and ManagementHealth disparities and outcomes

Cited by 350

Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US

Eberly, L. A., Yang, L., Essien, U. R., Eneanya, N. D., Julien, H. M., Luo, J., Nathan, A. S., Khatana, S. A. M., Dayoub, E. J., Fanaroff, A. C., et al. (2021) · JAMA Health Forum

Diabetes Treatment and ManagementHealth disparities and outcomes

Cited by 288

Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults

Teufel, F., Seiglie, J. A., Geldsetzer, P., Theilmann, M., Marcus, M. E., Ebert, C., Arboleda, W. A. L., Agoudavi, K., Andall-Brereton, G., Aryal, K. K., et al. (2021) · The Lancet

Diabetes, Cardiovascular Risks, and LipoproteinsObesity, Physical Activity, Diet

Cited by 159

Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II

Essien, U. R., Holmes, D. N., Jackson, L. R., Fonarow, G. C., Mahaffey, K. W., Reiffel, J. A., Steinberg, B. A., Allen, L. A., Chan, P. S., Freeman, J. V., et al. (2018) · JAMA Cardiology

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 155

Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020

Jacobs, J. A., Addo, D. K., Zheutlin, A. R., Derington, C. G., Essien, U. R., Navar, A. M., Hernandez, I., Lloyd-Jones, D. M., King, J. B., Rao, S., et al. (2023) · JAMA Cardiology

Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular Prevention

Cited by 97

Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes

Essien, U. R., Singh, B., Swabe, G., Johnson, A. E., Eberly, L. A., Wadhera, R. K., Breathett, K., Vaduganathan, M., & Magnani, J. W. (2023) · JAMA Network Open

Medication Adherence and ComplianceDiabetes Treatment and Management

Cited by 69

Neighborhoods with Greater Prevalence of Minority Residents Have Lower Continuous Positive Airway Pressure Adherence

Borker, P. V., Carmona, E., Essien, U. R., Saeed, G. J., Nouraie, S. M., Bakker, J. P., Stitt, C. J., Aloia, M. S., & Patel, S. R. (2021) · American Journal of Respiratory and Critical Care Medicine

Obstructive Sleep Apnea ResearchHealth disparities and outcomes

Cited by 48